LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Months after exiting its listed Indian subsidiary, Novartis has reinforced its commitment to the country's innovative ...
April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, announces greater capabilities to treat prostate cancer using the injectable ...
Salivary gland toxicity from radiopharmaceutical therapy—particularly from alpha-emitting therapies like 225 Ac-PSMA—is a critical dose-limiting side effect, often leading to debilitating dry mouth.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
June 2026 - Clinical Trial and Case Study Results Highlight Diagnostic and Therapeutic Potential of SAR-bisPSMA Portfolio.
Every year, more than 27,000 Ghanaians are diagnosed with cancer, while nearly 18,000 lose their lives to it .
Press releases are posted on Independent.com as a free community service. April 24, 2025 (Santa Barbara, CA) The Nuclear Medicine Department at Ridley-Tree Cancer Center, now part of Sutter Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results